(VIANEWS) - Eagle Bancorp Montana (EBMT), Amkor Technology (AMKR), TriCo Bancshares (TCBK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Eagle Bancorp Montana (EBMT)
32.7% sales growth and 11.75% return on equity
Eagle Bancorp Montana, Inc. operates as the bank holding company for Opportunity Bank of Montana that provides various retail banking products and services to small businesses and individuals in Montana.
Eagle Bancorp Montana's sales growth this year is anticipated to be 7.9% and 33.6% for next year.
Year-on-year quarterly revenue growth grew by 0.9%, now sitting on 95.18M for the twelve trailing months.
Volume
Today's last reported volume for Eagle Bancorp Montana is 7474 which is 4.21% above its average volume of 7172.
Eagle Bancorp Montana's sales growth for the next quarter is 32.7%. The company's growth estimates for the current quarter and the next is a negative 23.7% and negative -38.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.75%.
Volatility
Eagle Bancorp Montana's last day, last week, and last month's current intraday variation average was 1.30%, 0.81%, and 0.97%, respectively.
Eagle Bancorp Montana's highest amplitude of average volatility was 2.60% (day), 2.61% (last week), and 1.89% (last month), respectively.
Eagle Bancorp Montana's Stock Yearly Top and Bottom Value
Eagle Bancorp Montana's stock is valued at $22.25 at 15:22 EST, way under its 52-week high of $26.13 and way higher than its 52-week low of $20.00.
Eagle Bancorp Montana's Moving Average
Eagle Bancorp Montana's value is under its 50-day moving average of $22.49 and under its 200-day moving average of $23.00.2. Amkor Technology (AMKR)
20.6% sales growth and 22.29% return on equity
Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally.
Amkor Technology's sales growth this year is anticipated to be 21.5% and 9% for next year.
Year-on-year quarterly revenue growth grew by 24.1%, now sitting on 5.78B for the twelve trailing months.
Volume
Today's last reported volume for Amkor Technology is 215175 which is 78.44% below its average volume of 998413.
Amkor Technology's sales growth for the next quarter is 20.6%. The company's growth estimates for the current quarter and the next is a negative 0% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.29%.
Volatility
Amkor Technology's last day, last week, and last month's current intraday variation average was 3.68%, 2.38%, and 3.32%, respectively.
Amkor Technology's highest amplitude of average volatility was 3.76% (day), 2.82% (last week), and 4.20% (last month), respectively.
Amkor Technology's Stock Yearly Top and Bottom Value
Amkor Technology's stock is valued at $23.13 at 15:22 EST, way below its 52-week high of $29.50 and way above its 52-week low of $14.60.
Amkor Technology's Moving Average
Amkor Technology's value is below its 50-day moving average of $23.31 and below its 200-day moving average of $23.60.3. TriCo Bancshares (TCBK)
15.4% sales growth and 12% return on equity
TriCo Bancshares operates as a bank holding company for Tri Counties Bank that provides commercial banking services to individual and corporate customers.
TriCo Bancshares's sales growth this year is anticipated to be 6.9% and 14.6% for next year.
Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 334.74M for the twelve trailing months.
Volume
Today's last reported volume for TriCo Bancshares is 27877 which is 59.38% below its average volume of 68641.
TriCo Bancshares's sales growth for the next quarter is 15.4%. The company's growth estimates for the ongoing quarter and the next is 8.9% and negative -31%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12%.
Volatility
TriCo Bancshares's last day, last week, and last month's current intraday variation average was 0.79%, 1.73%, and 1.52%, respectively.
TriCo Bancshares's highest amplitude of average volatility was 1.05% (day), 2.28% (last week), and 2.78% (last month), respectively.
TriCo Bancshares's Stock Yearly Top and Bottom Value
TriCo Bancshares's stock is valued at $41.99 at 15:22 EST, way under its 52-week high of $51.66 and way higher than its 52-week low of $34.32.
TriCo Bancshares's Moving Average
TriCo Bancshares's worth is under its 50-day moving average of $43.98 and under its 200-day moving average of $43.96.4. WNS (WNS)
14.2% sales growth and 17.45% return on equity
WNS (Holdings) Limited, a business process management (BPM) company, provides data, voice, analytical, and business transformation services worldwide.
WNS's sales growth this year is expected to be 16.1% and 11.8% for next year.
Year-on-year quarterly revenue growth grew by 22.9%, now sitting on 1.01B for the twelve trailing months.
Volume
Today's last reported volume for WNS is 153164 which is 6.83% above its average volume of 143362.
WNS's sales growth is a negative 0% for the current quarter and 14.2% for the next. The company's growth estimates for the present quarter and the next is 5.1% and 19.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.45%.
Volatility
WNS's last day, last week, and last month's current intraday variation average was 1.60%, 0.92%, and 1.22%, respectively.
WNS's highest amplitude of average volatility was 3.24% (day), 2.41% (last week), and 2.33% (last month), respectively.
WNS's Stock Yearly Top and Bottom Value
WNS's stock is valued at $84.20 at 15:22 EST, below its 52-week high of $91.03 and way above its 52-week low of $66.20.
WNS's Moving Average
WNS's value is under its 50-day moving average of $86.07 and higher than its 200-day moving average of $79.78.5. Ambev (ABEV)
11.9% sales growth and 17.02% return on equity
Ambev S.A., through its subsidiaries, produces, distributes, and sells beer, draft beer, carbonated soft drinks (CSD), other non-alcoholic beverages, malt, and food products in the Americas.
Ambev's sales growth this year is anticipated to be 15.4% and 5.4% for next year.
Year-on-year quarterly revenue growth grew by 32%, now sitting on 62.42B for the twelve trailing months.
Volume
Today's last reported volume for Ambev is 9834310 which is 58.56% below its average volume of 23733100.
Ambev's sales growth for the next quarter is 11.9%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative -50%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.02%.
Volatility
Ambev's last day, last week, and last month's current intraday variation average was 0.74%, 0.37%, and 0.79%, respectively.
Ambev's highest amplitude of average volatility was 1.49% (day), 1.41% (last week), and 2.11% (last month), respectively.
Ambev's Stock Yearly Top and Bottom Value
Ambev's stock is valued at $2.73 at 15:22 EST, way below its 52-week high of $3.95 and way higher than its 52-week low of $2.38.
Ambev's Moving Average
Ambev's worth is under its 50-day moving average of $2.85 and way below its 200-day moving average of $3.18.6. Regional Management Corp. (RM)
10.2% sales growth and 26.45% return on equity
Regional Management Corp., a diversified consumer finance company, provides various installment loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders.
Regional Management Corp.'s sales growth this year is anticipated to be 8.2% and 12.3% for next year.
Year-on-year quarterly revenue growth grew by 11.1%, now sitting on 375.61M for the twelve trailing months.
Volume
Today's last reported volume for Regional Management Corp. is 117209 which is 78.11% above its average volume of 65806.
Regional Management Corp.'s sales growth for the next quarter is 10.2%. The company's growth estimates for the current quarter and the next is 54.5% and 28.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.45%.
Volatility
Regional Management Corp.'s last day, last week, and last month's current intraday variation average was 0.22%, 0.90%, and 1.90%, respectively.
Regional Management Corp.'s highest amplitude of average volatility was 2.65% (day), 3.22% (last week), and 3.90% (last month), respectively.
Regional Management Corp.'s Stock Yearly Top and Bottom Value
Regional Management Corp.'s stock is valued at $54.31 at 15:22 EST, way below its 52-week high of $67.60 and way above its 52-week low of $26.61.
Regional Management Corp.'s Moving Average
Regional Management Corp.'s value is below its 50-day moving average of $57.21 and higher than its 200-day moving average of $50.11.7. Supernus Pharmaceuticals (SUPN)
9.4% sales growth and 10.76% return on equity
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States.
Supernus Pharmaceuticals's sales growth this year is expected to be 8.9% and 19% for next year.
Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 564.28M for the twelve trailing months.
Volume
Today's last reported volume for Supernus Pharmaceuticals is 123348 which is 72.13% below its average volume of 442708.
Supernus Pharmaceuticals's sales growth for the next quarter is 9.4%. The company's growth estimates for the present quarter and the next is a negative 50.9% and 236.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.76%.
Volatility
Supernus Pharmaceuticals's last day, last week, and last month's current intraday variation average was 0.23%, 1.81%, and 1.93%, respectively.
Supernus Pharmaceuticals's highest amplitude of average volatility was 2.88% (day), 5.05% (last week), and 4.53% (last month), respectively.
Supernus Pharmaceuticals's Stock Yearly Top and Bottom Value
Supernus Pharmaceuticals's stock is valued at $30.80 at 15:22 EST, way under its 52-week high of $34.50 and way above its 52-week low of $23.15.
Supernus Pharmaceuticals's Moving Average
Supernus Pharmaceuticals's value is under its 50-day moving average of $30.83 and higher than its 200-day moving average of $29.01.Previous days news about Supernus Pharmaceuticals(SUPN)
- According to MarketWatch on Tuesday, 28 December, "AbbVie ABBV, AmerisourceBergen ABC, Cigna CI, Allscripts MDRX and Supernus Pharmaceuticals SUPN are just a few of the mentions."
8. PacWest Bancorp (PACW)
8.7% sales growth and 15.87% return on equity
PacWest Bancorp operates as the bank holding company for Pacific Western Bank that provides various banking products and services.
PacWest Bancorp's sales growth this year is anticipated to be 8.4% and 9.6% for next year.
Year-on-year quarterly revenue growth grew by 80.3%, now sitting on 1.39B for the twelve trailing months.
Volume
Today's last reported volume for PacWest Bancorp is 374560 which is 49.45% below its average volume of 740990.
PacWest Bancorp's sales growth is a negative 0% for the present quarter and 8.7% for the next. The company's growth estimates for the present quarter and the next is 163.2% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.87%.
Volatility
PacWest Bancorp's last day, last week, and last month's current intraday variation average was 0.99%, 2.28%, and 2.06%, respectively.
PacWest Bancorp's highest amplitude of average volatility was 1.71% (day), 3.77% (last week), and 3.73% (last month), respectively.
PacWest Bancorp's Stock Yearly Top and Bottom Value
PacWest Bancorp's stock is valued at $43.96 at 15:22 EST, way under its 52-week high of $50.42 and way above its 52-week low of $24.27.